Form S-3 TScan Therapeutics, Inc.
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/2/2026
- S&P 500, Dow rise as AI boost counters US-Iran tensions
- Oil retreats from one-month high as traders weigh supply risks
- Dell again lifts annual forecasts as AI demand powers record results
- Could Apple’s foldable iPhone be a $14B opportunity? Morgan Stanley weighs in
- Uber stock gains 2% as tech giant cuts 3,300 jobs in major restructuring
- GoPro to merge with Starman Optical in $285M recapitalization deal
- GoPro (GPRO) Halted, News Pending
- Wall Street ends lower as higher yields, rising oil prices mark shaky start to September
- Gap taps Coach architect Reed Krakoff for $29.95-$498 handbag line
- Google defeats US bid to force ad tech sale
TScan Therapeutics, Inc (TCRX) Files $300M Mixed Shelf
March 5, 2025 4:28 PM ESTTScan Therapeutics, Inc (NASDAQ: TCRX) has filed $300,000,000 mixed shelf of:
Voting Common Stock
Non-Voting Common Stock
Preferred Stock
Debt Securities
Warrants
Units
... More